Org.nr 922 558 221 AS · OSLO · 46.460 Engroshandel med apotekvarer og medisinske varer Gaustadalléen 21, 0349 OSLO Latest filing: Årsregnskap 2025 · approved 07.05.2026 · journal 2026 453699 Analysis generated: 07 Sep 2026 · Auto-onboard

AFYX NORWAY AS

AFYX NORWAY AS · 7 published annual accounts (2019–2025). Latest year revenue 19.4m NOK, net result 257.3k NOK, equity 4.8m NOK, cash 3.8m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2019–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 19.4m

Operating income / revenue in 2025.

Did they make money?
257.3k

Net result for 2025.

What’s left in the company
Equity 4.8m

Book equity at year-end.

Cash
3.8m

Bank deposits and cash (when disclosed).

Key figures

Revenue / sales
19 391 200
NOK · [R2025]
Net result
257 304
NOK · [R2025]
Equity
4 772 568
NOK · [R2025]
Cash
3 756 499
NOK · [R2025]
Total assets
8 917 781
NOK · [R2025]
Paid-in equity
16 180
NOK · [R2025]

7-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.